ID   BCAR1_RAT               Reviewed;         968 AA.
AC   Q63767; Q63766;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 186.
DE   RecName: Full=Breast cancer anti-estrogen resistance protein 1;
DE   AltName: Full=CRK-associated substrate;
DE   AltName: Full=p130cas;
GN   Name=Bcar1; Synonyms=Cas, Crkas;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Fibroblast;
RX   PubMed=8070403; DOI=10.1002/j.1460-2075.1994.tb06684.x;
RA   Sakai R., Iwamatsu A., Hirano N., Ogawa S., Tanaka T., Mano H., Yazaki Y.,
RA   Hirai H.;
RT   "A novel signaling molecule, p130, forms stable complexes in vivo with v-
RT   Crk and v-Src in a tyrosine phosphorylation-dependent manner.";
RL   EMBO J. 13:3748-3756(1994).
RN   [2]
RP   PHOSPHORYLATION AT TYR-347 BY ABL1.
RX   PubMed=7780740; DOI=10.1016/s0960-9822(95)00060-1;
RA   Mayer B.J., Hirai H., Sakai R.;
RT   "Evidence that SH2 domains promote processive phosphorylation by protein-
RT   tyrosine kinases.";
RL   Curr. Biol. 5:296-305(1995).
RN   [3]
RP   PHOSPHORYLATION AT TYROSINE RESIDUES BY PTK2/FAK1.
RX   PubMed=9360983; DOI=10.1074/jbc.272.46.29083;
RA   Tachibana K., Urano T., Fujita H., Ohashi Y., Kamiguchi K., Iwata S.,
RA   Hirai H., Morimoto C.;
RT   "Tyrosine phosphorylation of Crk-associated substrates by focal adhesion
RT   kinase. A putative mechanism for the integrin-mediated tyrosine
RT   phosphorylation of Crk-associated substrates.";
RL   J. Biol. Chem. 272:29083-29090(1997).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-737, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Docking protein which plays a central coordinating role for
CC       tyrosine-kinase-based signaling related to cell adhesion (By
CC       similarity). Implicated in induction of cell migration and cell
CC       branching (By similarity). Involved in the BCAR3-mediated inhibition of
CC       TGFB signaling (By similarity). {ECO:0000250|UniProtKB:P56945,
CC       ECO:0000250|UniProtKB:Q61140}.
CC   -!- SUBUNIT: Forms complexes in vivo with PTK2/FAK1, adapter protein CRKL
CC       and LYN kinase. Can heterodimerize with NEDD9. Component of a complex
CC       comprised of SH2D3C, BCAR1/CAS, and CRK (By similarity). Within the
CC       complex, interacts with SH2D3C (via C-terminus), and CRK (By
CC       similarity). Part of a complex comprised of PTPRA, BCAR1, BCAR3 (via
CC       SH2 domain) and SRC; the formation of the complex is dependent on
CC       intergrin mediated-tyrosine phosphorylation of PTPRA (By similarity).
CC       Interacts with BCAR3 (via Ras-GEF domain); the interaction regulates
CC       adhesion-dependent serine phosphorylation (By similarity). Interacts
CC       with SMAD2 and SMAD3 (By similarity). Interacts with NPHP1 (By
CC       similarity). Interacts with PTK2B/PYK2 (By similarity). Interacts (via
CC       C-terminus) with SH2D3C/CHAT isoform 2 (via C-terminus) (By
CC       similarity). Interacts with activated CSPG4. Interacts with BMX,
CC       INPPL1/SHIP2 and PEAK1 (By similarity). Part of a collagen stimulated
CC       complex involved in cell migration composed of CDC42, CRK, TNK2 and
CC       BCAR1/p130cas (By similarity). Interacts with TNK2 via SH3 domains.
CC       Interacts with PTK2B/PYK2 (By similarity). Interacts (when tyrosine-
CC       phosphorylated) with tensin TNS1; the interaction is increased by
CC       phosphorylation of TNS1 (By similarity). {ECO:0000250|UniProtKB:P56945,
CC       ECO:0000250|UniProtKB:Q61140}.
CC   -!- INTERACTION:
CC       Q63767; P18031: PTPN1; Xeno; NbExp=5; IntAct=EBI-1176801, EBI-968788;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:Q61140}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q61140}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q61140}. Note=Unphosphorylated form localizes in
CC       the cytoplasm (By similarity). Localizes to focal adhesion sites
CC       following integrin engagement (By similarity).
CC       {ECO:0000250|UniProtKB:Q61140}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q63767-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q63767-2; Sequence=VSP_004135;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Higher expression in lung,
CC       intestine and testis.
CC   -!- DOMAIN: Contains a central domain (substrate domain) containing
CC       multiple potential SH2-binding sites and a C-terminal domain containing
CC       a divergent helix-loop-helix (HLH) motif. The SH2-binding sites
CC       putatively bind CRK, NCK and ABL SH2 domains. The HLH motif is
CC       absolutely required for the induction of pseudohyphal growth in yeast
CC       and mediates heterodimerization with NEDD9.
CC   -!- DOMAIN: A serine-rich region promotes activation of the serum response
CC       element (SRE).
CC   -!- DOMAIN: The SH3 domain is necessary for the localization of the protein
CC       to focal adhesions and interacts with one proline-rich region of
CC       PTK2/FAK1.
CC   -!- PTM: PTK2/FAK1 activation mediates phosphorylation at the YDYVHL motif;
CC       phosphorylation is most likely catalyzed by SRC family members. SRC-
CC       family kinases are recruited to the phosphorylated sites and can
CC       phosphorylate other tyrosine residues. Tyrosine phosphorylation is
CC       triggered by integrin mediated adhesion of cells to the extracellular
CC       matrix. {ECO:0000269|PubMed:7780740, ECO:0000269|PubMed:9360983}.
CC   -!- PTM: Phosphorylated by SRC kinase in a EDN1- and PTK2B-mediated manner;
CC       phosphorylation strengthens its interaction with BCAR3 as part of the
CC       PTK2B/BCAR1/BCAR3/RAP1 signaling pathway.
CC       {ECO:0000250|UniProtKB:P56945}.
CC   -!- PTM: Dephosphorylated by PTPN14 at Tyr-226. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the CAS family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D29766; BAA06169.1; -; mRNA.
DR   EMBL; D29766; BAA06170.1; -; mRNA.
DR   PIR; S46992; S46992.
DR   RefSeq; NP_037063.1; NM_012931.1.
DR   PDB; 1X27; X-ray; 2.70 A; I/J/K/L/M/N=759-767.
DR   PDB; 1Z23; NMR; -; A=546-708.
DR   PDBsum; 1X27; -.
DR   PDBsum; 1Z23; -.
DR   AlphaFoldDB; Q63767; -.
DR   BMRB; Q63767; -.
DR   SMR; Q63767; -.
DR   BioGRID; 247449; 5.
DR   CORUM; Q63767; -.
DR   IntAct; Q63767; 7.
DR   MINT; Q63767; -.
DR   STRING; 10116.ENSRNOP00000039940; -.
DR   iPTMnet; Q63767; -.
DR   PhosphoSitePlus; Q63767; -.
DR   PaxDb; 10116-ENSRNOP00000039940; -.
DR   GeneID; 25414; -.
DR   KEGG; rno:25414; -.
DR   UCSC; RGD:2406; rat. [Q63767-1]
DR   AGR; RGD:2406; -.
DR   CTD; 9564; -.
DR   RGD; 2406; Bcar1.
DR   eggNOG; ENOG502QQHE; Eukaryota.
DR   InParanoid; Q63767; -.
DR   OrthoDB; 2902504at2759; -.
DR   PhylomeDB; Q63767; -.
DR   Reactome; R-RNO-186763; Downstream signal transduction.
DR   Reactome; R-RNO-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-8849471; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases.
DR   EvolutionaryTrace; Q63767; -.
DR   PRO; PR:Q63767; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0015629; C:actin cytoskeleton; ISO:RGD.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0001726; C:ruffle; ISS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IMP:RGD.
DR   GO; GO:0007015; P:actin filament organization; ISS:UniProtKB.
DR   GO; GO:0050851; P:antigen receptor-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0060326; P:cell chemotaxis; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; IMP:RGD.
DR   GO; GO:0007169; P:cell surface receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   GO; GO:1990859; P:cellular response to endothelin; IPI:RGD.
DR   GO; GO:0035729; P:cellular response to hepatocyte growth factor stimulus; ISO:RGD.
DR   GO; GO:0071732; P:cellular response to nitric oxide; IPI:RGD.
DR   GO; GO:0086100; P:endothelin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048012; P:hepatocyte growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:1900025; P:negative regulation of substrate adhesion-dependent cell spreading; IMP:RGD.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; ISO:RGD.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; ISO:RGD.
DR   CDD; cd11569; FAT-like_BCAR1_C; 1.
DR   CDD; cd11552; Serine_rich_BCAR1; 1.
DR   CDD; cd12001; SH3_BCAR1; 1.
DR   Gene3D; 1.20.120.230; Alpha-catenin/vinculin-like; 1.
DR   Gene3D; 1.20.120.830; Serine-rich domain; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   InterPro; IPR046976; BCAR1_C.
DR   InterPro; IPR035745; BCAR1_SH3.
DR   InterPro; IPR021901; CAS_C.
DR   InterPro; IPR037362; CAS_fam.
DR   InterPro; IPR014928; Serine_rich_dom.
DR   InterPro; IPR038319; Serine_rich_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR10654:SF15; BREAST CANCER ANTI-ESTROGEN RESISTANCE PROTEIN 1; 1.
DR   PANTHER; PTHR10654; CAS SCAFFOLDING PROTEIN; 1.
DR   Pfam; PF12026; CAS_C; 1.
DR   Pfam; PF08824; Serine_rich; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR01887; SPECTRNALPHA.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell adhesion;
KW   Cell junction; Cell projection; Cytoplasm; Direct protein sequencing;
KW   Phosphoprotein; Reference proteome; SH3 domain; SH3-binding.
FT   CHAIN           1..968
FT                   /note="Breast cancer anti-estrogen resistance protein 1"
FT                   /id="PRO_0000064856"
FT   DOMAIN          97..159
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          164..277
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          213..514
FT                   /note="Substrate for kinases"
FT   REGION          393..416
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          503..544
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          705..756
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          844..894
FT                   /note="Divergent helix-loop-helix motif"
FT   MOTIF           733..741
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        166..188
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        199..257
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        523..543
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        717..751
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P56945"
FT   MOD_RES         226
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000250|UniProtKB:P56945"
FT   MOD_RES         237
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56945"
FT   MOD_RES         332
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61140"
FT   MOD_RES         347
FT                   /note="Phosphotyrosine; by ABL1"
FT                   /evidence="ECO:0000269|PubMed:7780740"
FT   MOD_RES         367
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P56945"
FT   MOD_RES         390
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56945"
FT   MOD_RES         460
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61140"
FT   MOD_RES         470
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61140"
FT   MOD_RES         508
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61140"
FT   MOD_RES         526
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56945"
FT   MOD_RES         535
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56945"
FT   MOD_RES         737
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         5..98
FT                   /note="Missing (in isoform Short)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004135"
FT   HELIX           554..581
FT                   /evidence="ECO:0007829|PDB:1Z23"
FT   STRAND          591..594
FT                   /evidence="ECO:0007829|PDB:1Z23"
FT   HELIX           599..624
FT                   /evidence="ECO:0007829|PDB:1Z23"
FT   HELIX           634..661
FT                   /evidence="ECO:0007829|PDB:1Z23"
FT   STRAND          664..666
FT                   /evidence="ECO:0007829|PDB:1Z23"
FT   HELIX           671..702
FT                   /evidence="ECO:0007829|PDB:1Z23"
SQ   SEQUENCE   968 AA;  104262 MW;  E861641BFD68D377 CRC64;
     MKYLVSVGAG PARRAGGLED VSWGPRVSRR PQSYRAARHV NESLPRSAFR VPAAHGASVT
     PSAALGSGLP ETQPEAVCRG TEKPRFAEGC KPAASRDKNV LAKALYDNVA ESPDELSFRK
     GDIMTVLERD TQGLDGWWLC SLHGRQGIVP GNRLKILVGM YDKKPAAPGP GPPATPPQPQ
     PSLPQGVHTP VPPASQYSPM LPTAYQPQPD NVYLVPTPSK TQQGLYQAPG PNPQFQSPPA
     KQTSTFSKQT PHHSFPSPAT DLYQVPPGPG SPAQDIYQVP PSAGTGHDIY QVPPSLDTRS
     WEGTKPPAKV VVPTRVGQGY VYEASQAEQD EYDTPRHLLA PGSQDIYDVP PVRGLLPNQY
     GQEVYDTPPM AVKGPNGRDP LLDVYDVPPS VEKGLPPSNH HSVYDVPPSV SKDVPDGPLL
     REETYDVPPA FAKPKPFDPT RHPLILAAPP PDSPPAEDVY DVPPPAPDLY DVPPGLRRPG
     PGTLYDVPRE RVLPPEVADG SVIDDGVYAV PPPAEREAPT DGKRLSASST GSTRSSQSAS
     SLEVVVPGRE PLELEVAVET LARLQQGVST TVAHLLDLVG SASGPGGWRS TSEPQEPPVQ
     DLKAAVAAVH GAVHELLEFA RSAVSSATHT SDRTLHAKLS RQLQKMEDVY QTLVVHGQVL
     DSGRGGPGFT LDDLDRLVAC SRAVPEDAKQ LASFLHGNAS LLFRRTKAPG PGPEGSSSLH
     LNPTDKASSI QSRPLPSPPK FTSQDSPDGQ YENSEGGWME DYDYVHLQGK EEFEKTQKEL
     LEKGNIVRQG KGQLELQQLK QFERLEQEVS RPIDHDLANW TPAQPLVPGR TGGLGPSDRQ
     LLLFYLEQCE ANLTTLTDAV DAFFTAVATN QPPKIFVAHS KFVILSAHKL VFIGDTLSRQ
     AKAADVRSKV THYSNLLCDL LRGIVATTKA AALQYPSPSA AQDMVDRVKE LGHSTQQFRR
     VLGQLAAA
//
